Previous preclinical and clinical studies have reported that GDNF, and its receptor alpha1 (GFRα1), levels in the brain were diminished in patients with AD and in a 3XTg AD mouse model [61,88,89]. This evidence concerns the gene GFRA1 and Alzheimer disease.